Log in
Enquire now
Acorn Biolabs

Acorn Biolabs

Acorn Biolabs is a biotechnology company offering long-term human cell cryopreservation.

OverviewStructured DataIssuesContributors

Contents

acorn.me
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biology
Biology
Stem cell
Stem cell
Healthcare
Healthcare
Diabetes mellitus
Diabetes mellitus
Biotechnology
Biotechnology
Technology
Technology
...
Location
Toronto
Toronto
0
California
California
Canada
Canada
Ontario
Ontario
B2X
B2C
B2C
CEO
Drew Taylor
Drew Taylor
Founder
Steven ten Holder
Steven ten Holder
‌
Patrick Pumputis
AngelList URL
angel.co/acorn-cryotech
Date Incorporated
2017
Number of Employees (Ranges)
1 – 10
Email Address
inf@acorn.me
Full Address
661 University Avenue MaRS Centre, West Tower, Suite 1300 Toronto, Ontario M5G0B7, CA
Investors
Epic Capital Management
Epic Capital Management
Real Ventures
Real Ventures
Pool Global Partners
Pool Global Partners
Globalive Technology
Globalive Technology
Founded Date
2017
Total Funding Amount (USD)
3,300,000
Latest Funding Round Date
January 16, 2019
Competitors
Shivom
Shivom
Latest Funding Type
Seed
Seed
Patents Assigned (Count)
1
Wellfound ID
acorn-cryotech

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
3,300,000

Acorn Biolabs is a company that looks to provide genetic engineering technologies that can prolong the human life span. The company was founded by Drew Taylor in 2017, in Kitchener, Ontario, Canada.

The company looks to develop methods of cryopreservation through means such as stem cell storage, cell and gene therapy, bio banking, and stem cell collection. The service that Acorn Biolabs offers is to freeze a patient's cells for the purpose of fighting diseases in the future.

The company is able to transform any cell into a stem cell, preserve the cells in order to provide personal regenerative medicines, and is able to do so through the collection of a few hairs. The process includes reprogramming adult cells into stem cells. They are able to grow tissues, and 3D print organs. However, freezing the cells allows the company to use them for a specific use case in the future.

Acorn Biolabs has held over one-thousand clinical trials and has sixty-thousand patients enrolled with the goal of tackling diseases like Alzheimer's or diabetes, healing injuries anywhere in the body, regrowing skin, repairing sight, providing 3D printed implant organs, and more.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Acorn Biolabs

https://www.youtube.com/watch?v=QDbBXPK1J38

July 6, 2018

Cryopreservation company, Acorn Biolabs closes $3.3M seed funding and ramps towards consumer launch

Acorn Biolabs

https://www.prnewswire.com/news-releases/cryopreservation-company-acorn-biolabs-closes-3-3m-seed-funding-and-ramps-towards-consumer-launch-300779814.html

Web

References

Find more companies like Acorn Biolabs

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.